LFT slightly high. There is no pain. No yellowing of the eyes. No weakness. So it is easy to brush it aside. But the liver rarely shouts in the beginning. It whispers.Liver Function Tests, or LFTs, ...

The FDA has liberated the second of two Intellia Therapeutics clinical trials that were put on hold last October following a report of serious liver toxicity that later led to death.

Liver enzymes help break down food and turn it into energy and nutritional elements, among other things. Elevated levels ...

Juxtapid has been available to treat adults with homozygous familial hypercholesterolemia (HoFH), a rare genetic disorder that causes extremely high levels of LDL cholesterol.

Doctors say that fatty liver disease has become a leading indication for transplantation in India.

Losing a battle you cannot see is one of the biggest challenges in medicine. And for many Americans, that quiet fight happens ...

A new screening tool can identify the hidden driver of a silent killer through standard blood work, bypassing the need to ask ...

The Swiss drugmaker reported a phase 3 win for fenebrutinib over Sanofi's Aubagio in RMS in November. In that study, Roche linked its drug candidate to a 59% reduction in the annualized relapse rate ...

A woman whose son was stillborn has said her severe symptoms were dismissed as “nothing to worry about” by NHS hospital staff but she “still feels like a mother despite it all”. Natasha Anderson, 34, ...

For many years, scientists have been puzzled by individuals who live in high-elevation areas throughout the world. Surveys of high-altitude populations, from areas of the Andes to regions of the ...

Approval expands indication of JUXTAPID® to include children 2 years of age and older with HoFH. This announcement was made ...